NEXN
Basic information
Region (hg38): 1:77888513-77943895
Links
Phenotypes
GenCC
Source:
- hypertrophic cardiomyopathy 20 (Limited), mode of inheritance: AD
- familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
- dilated cardiomyopathy 1CC (Limited), mode of inheritance: AD
- hypertrophic cardiomyopathy 20 (Limited), mode of inheritance: AD
- hypertrophic cardiomyopathy (Limited), mode of inheritance: AD
- dilated cardiomyopathy (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, familial hypertrophic, 20; Cardiomyopathy, dilated, 1CC | AD | Cardiovascular | Surveillance (eg, including echocardiogram/electocardiogram) and preventive measures, including medical management, may reduce morbidity and severe sequelae such as sudden cardiac death; Cardiac transplantation has ben reported | Cardiovascular | 19881492; 20970104 |
ClinVar
This is a list of variants' phenotypes submitted to
- Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 (8 variants)
- Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC (5 variants)
- Dilated cardiomyopathy 1CC (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEXN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 123 | 126 | ||||
missense | 327 | 338 | ||||
nonsense | 12 | 16 | ||||
start loss | 1 | |||||
frameshift | 29 | 38 | ||||
inframe indel | 17 | 17 | ||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 12 | 9 | 21 | |||
non coding | 49 | 21 | 74 | |||
Total | 13 | 5 | 397 | 179 | 25 |
Highest pathogenic variant AF is 0.00000658
Variants in NEXN
This is a list of pathogenic ClinVar variants found in the NEXN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-77888598-A-ACGG | Dilated Cardiomyopathy, Dominant • Hypertrophic cardiomyopathy | Uncertain significance (Jun 14, 2016) | ||
1-77888754-T-C | not specified | Benign (Feb 24, 2014) | ||
1-77888795-T-G | Likely benign (Jan 07, 2021) | |||
1-77888900-G-T | Benign (Jun 23, 2018) | |||
1-77916039-T-C | not specified | Benign (Sep 17, 2014) | ||
1-77916044-AT-A | Likely benign (Feb 13, 2024) | |||
1-77916064-T-A | not specified | Likely benign (Nov 02, 2017) | ||
1-77916073-C-A | not specified | Benign (Jun 23, 2014) | ||
1-77916097-T-C | not specified | Uncertain significance (Jul 24, 2014) | ||
1-77916106-C-T | Cardiovascular phenotype | Uncertain significance (Jul 30, 2020) | ||
1-77916107-A-C | Cardiovascular phenotype • Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 | Uncertain significance (Jun 09, 2023) | ||
1-77916110-AATG-A | Cardiovascular phenotype • Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 | Uncertain significance (Oct 25, 2023) | ||
1-77916114-A-T | Cardiovascular phenotype • NEXN-related disorder | Uncertain significance (Mar 21, 2022) | ||
1-77916121-C-T | Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 | Likely benign (Dec 07, 2023) | ||
1-77916129-CTGAGG-C | Cardiovascular phenotype | Uncertain significance (Jun 09, 2023) | ||
1-77916133-G-A | Cardiovascular phenotype | Uncertain significance (Aug 10, 2022) | ||
1-77916140-C-T | Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC | Likely benign (May 03, 2021) | ||
1-77916333-T-C | Benign (Jun 19, 2018) | |||
1-77916353-A-C | Benign (Jun 14, 2018) | |||
1-77917475-AT-A | Benign (Sep 27, 2018) | |||
1-77917554-C-A | Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC | Likely benign (Mar 31, 2023) | ||
1-77917557-C-T | Likely benign (Nov 26, 2019) | |||
1-77917567-T-G | Cardiovascular phenotype | Uncertain significance (May 11, 2023) | ||
1-77917570-T-C | Cardiovascular phenotype | Uncertain significance (Feb 11, 2022) | ||
1-77917581-T-C | Cardiomyopathy | Uncertain significance (Mar 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NEXN | protein_coding | protein_coding | ENST00000334785 | 12 | 55383 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.91e-11 | 0.996 | 124707 | 1 | 83 | 124791 | 0.000337 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.208 | 354 | 343 | 1.03 | 0.0000175 | 4480 |
Missense in Polyphen | 115 | 104.97 | 1.0955 | 1304 | ||
Synonymous | 0.167 | 109 | 111 | 0.980 | 0.00000554 | 1132 |
Loss of Function | 2.72 | 24 | 43.3 | 0.554 | 0.00000257 | 521 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000441 | 0.000439 |
Ashkenazi Jewish | 0.0000994 | 0.0000993 |
East Asian | 0.000390 | 0.000389 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000463 | 0.000459 |
Middle Eastern | 0.000390 | 0.000389 |
South Asian | 0.000360 | 0.000327 |
Other | 0.000331 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in regulating cell migration through association with the actin cytoskeleton. Has an essential role in the maintenance of Z line and sarcomere integrity. {ECO:0000269|PubMed:12053183, ECO:0000269|PubMed:15823560, ECO:0000269|PubMed:19881492}.;
- Disease
- DISEASE: Cardiomyopathy, familial hypertrophic 20 (CMH20) [MIM:613876]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:20970104}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.929
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.34
Haploinsufficiency Scores
- pHI
- 0.192
- hipred
- N
- hipred_score
- 0.448
- ghis
- 0.539
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0145
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nexn
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype;
Zebrafish Information Network
- Gene name
- nexn
- Affected structure
- atrium
- Phenotype tag
- abnormal
- Phenotype quality
- increased width
Gene ontology
- Biological process
- homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;response to bacterium;regulation of cell migration;regulation of cytoskeleton organization;dendrite self-avoidance
- Cellular component
- cytoskeleton;plasma membrane;focal adhesion;Z disc;axon
- Molecular function
- structural constituent of muscle;actin filament binding;cell-cell adhesion mediator activity